Richard E. Waterman

Richard E. Waterman

ID: 1b83c147-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

Boehringer Ingelheim Seeks to Redefine a Biosimilar’s “Strength”

Biosimilars Law Bulletin · December 22, 2020

Claim Construction Arguments in Appeal Forfeited if Not Raised Before the Board

PTAB Law Blog · November 23, 2020

Venue Considerations for Hatch-Waxman and BPCIA Litigation

Biosimilars Law Bulletin · November 18, 2020

Still No Same Party Joinder and Joinder of New Issues through 35 U.S.C. § 315(c)

PTAB Law Blog · September 22, 2020

IPR Parties Joined under 315(c) Have Full Rights to Appeal

PTAB Law Blog · August 4, 2020

Practice Areas

Health Care and Life Sciences

Intellectual Property

Jurisdictions

Washington, D.C.